Marc Hodosh is President of TED MED, a conference he is re-launching in the fall of 2009, in partnership with TED founder, Richard Wurman.
Previously Marc led the Archon X PRIZE for Genomics a $10 million competition to inspire rapid and cost effective genome sequencing technology; which followed the highly successful $10 million Ansari Space X PRIZE.
He has been a consultant to inventor Dean Kamen at DEKA Research & Development and is also Chairman of Dean’s FIRST Robotics competition in Boston, inspiring thousands of high school students to pursue careers in science & technology.
Additionally, Marc founded and sold, ID One, which specialized in facial recognition technology for the U.S. military and intelligence communities. Just prior, he led business development at Viisage Technology, a publicly traded, biometric and secure ID company.
Marc’s first business endeavors began by inventing and importing a variety of consumer products from Asia, with distribution through Bed Bath & Beyond, QVC television, Toys-R-Us, and others. These products were acquired by the industry’s leader and continue to sell successfully at major retail outlets, worldwide.
Carol is a Fellow of the Society of Actuaries and has 20 years of healthcare experience. Carol is currently Humana’s VP of R&D where she’s pioneered the use of novel techniques in prediction and computational health intelligence to predict health severity, disease progression and consumer health behavior. She also leads Humana’s Health Service Research Center, focused on health services research, the psychology of health behavior change, pharmacovigilance, and personalized medicine research.
It’s boring putting “insurance” as my area of expertise. I’m interested in anything remotely related to health and anything that’s weird and cool with data and analytics. This includes everything from ubiquitous computing, distributed intelligence, personal health & sensor technologies, you name it.
I’m also interested in self-organizing systems, the self-organization, co-creation and emergence of meaning in social systems, and the “social life” of information, particularly in highly recursive topologies, pervasive information ecosystems, and/or asymmetric information landscapes. I like to do scary stuff with data, where “prediction meets people” and can help them in novel ways.
Dr. Joanna Mountain is a Senior Director of Research at 23andMe, Inc. of Mountain View, California, a company that provides consumers with access to personal genetic information. Dr. Mountain is also a consulting faculty member in the Department of Anthropology at Stanford University where she has specialized in the study of human evolutionary genetics. Dr. Mountain received her Ph.D. degree in Genetics from Stanford University having completed a B.S. degree through Stanford’s Mathematical Sciences program. After receiving her Ph.D., Dr. Mountain conducted postdoctoral research on human population genetics within the Integrative Biology Department at the University of California, Berkeley.
Broadly speaking, Dr. Mountain’s areas of interest include: phenotype and the interactions among genotype, environment, and culture; the extent to which genetic data can reveal details of human history; comparisons of genetic and linguistic variation among human populations; ethical issues regarding human genetics; biology, genetics, and concepts of race and ethnicity; the origins of and relationships among the peoples of Africa; and the development of statistical tools for analyzing population genetic data. Dr. Mountain has published scientific papers on a broad range of topics, from the genetic diversity of click-speaking peoples of eastern and southern Africa, to algorithms for discovering geographic ancestry of individuals, to the nature of the relationship between genetic diversity and categories of race and ethnicity. She has been the recipient of a number of academic awards, including grants from the National Science Foundation and National Institutes of Health.
Dr. Kraft is a Stanford and Harvard trained physician-scientist with over 20 years of innovative biomedical research and clinical experience. He is an NIH funded faculty member with the Stanford Institute for Stem Cell Biology and Regenerative Medicine and is on clinical faculty with the UCSF pediatric bone marrow transplantation service.
Daniel has extensive research experience focused on stem cell biology and immunology. In early research experience at the National Institutes of Health, he was the first to propose and demonstrate proof of concept for a monoclonal antibody based therapy for allergic disease, an approach later translated to a novel humanized antibody therapeutic by Genentech (Xolair). As a Howard Hughes research fellow at Stanford he discovered a novel population of developing human T-cells, which play a role in HIV infection. His research focus after returning to Stanford has been on stem cell derived immunotherapy, working to understand and engineer the stem cell niche, and new antibody based conditioning regimens for stem cell transplantation. He has multiple peer-reviewed publications including in the journals Science and Nature, book chapters, and has lectured extensively on stem cell biology and regenerative medicine.
Daniel has additional research and clinical expertise in aerospace medicine (serves as flight surgeon with an F-16 squadron in the California Air National Guard) with whom he has deployed to Nicaragua and Saudi Arabia. He has published physiology research with NASA, with whom he was recently a finalist for astronaut selection.
Dr. Kraft is founder and consulting chief medical officer for StemCor Systems, a venture and corporate funded clinical stage medical device company based on his inventions, developing tools to enable adult stem cell based regenerative therapies, including the FDA approved ‘’MarrowMiner’’, a device which enables the rapid, less invasive harvest of bone marrow stem cells.
While a resident at Harvard, Daniel founded, developed, and operated one of the first internet based marketplaces for medical students and professionals, The Online Medical Bookstore, which was acquired by Netivation.com in conjunction with its IPO. Daniel helped found and serves as advisor to Wellsphere.com and also served as an advisor to multiple biotechnology companies. He is a venture partner and Kauffman Fellow with Proteus Venture Partners.
Dr. Kraft obtained a degree in Biochemistry cum laude from Brown University, and went on to complete medical school at Stanford University, where he was a Howard Hughes Research Fellow and graduated with honors in research. After medical school Dr. Kraft completed the four-year Harvard Combined Residency in Internal Medicine and Pediatrics at the Massachusetts General Hospital and Boston Children’s Hospital. Dr. Kraft then returned to Stanford for fellowship training in Hematology/Oncology and an additional fellowship in Bone Marrow and Hematopoietic Stem Cell Transplantation and a postdoctoral research fellowship in the stem cell laboratory of Irv Weissman. He is board certified in Internal Medicine, Pediatrics and BE in Hematology/Oncology.
Reach business leaders and technology influencers at the Web 2.0 Summit. Call Marco Pardi at (415) 947-6216 or email firstname.lastname@example.org.
View a complete list of Web 2.0 Summit contacts.